Program Overview

Integrated Nutritional Support for Patients on GLP-1 Therapy for Weight Management

Structured, clinically supervised nutrition and lifestyle care designed to improve tolerance, reduce side effects, and optimise outcomes alongside GLP-1 therapy.

Why structured nutritional support matters with GLP-1 therapy

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for weight management and metabolic disorders. While clinically effective, they are associated with:

  • Significant appetite suppression
  • Gastrointestinal (GI) side effects such as constipation, diarrhoea, nausea, and bloating
  • Inadequate dietary adaptation, leading to suboptimal outcomes and poor adherence

Despite pharmacological efficacy, structured nutritional guidance is often lacking, resulting in avoidable side effects and compromised patient experience.

Fresh greens and hydration on a clean surface

Program Objective

Clinically supervised nutritional and lifestyle care, ensuring:

  • Improved treatment tolerance
  • Reduced GI adverse events
  • Optimised metabolic and weight loss outcomes
  • Enhanced patient compliance and satisfaction

Core Pillars

Three pillars guiding every patient journey

01

Appetite Modulation Management

  • Educating patients on physiological appetite suppression induced by GLP-1 therapy
  • Preventing under-eating, nutrient deficiencies, and muscle loss
  • Structured meal planning aligned with reduced hunger cues
02

Gastrointestinal Symptom Management

Early identification and management of:

  • Constipation
  • Diarrhoea
  • Bloating and discomfort
  • Addressing the mismatch between reduced appetite and habitual intake patterns
  • Personalized dietary adjustments to improve gut tolerance and digestion
03

Personalized Clinical Nutrition & Lifestyle Integration

Comprehensive assessment of:

  • Dietary patterns
  • Lifestyle behaviors
  • Medical history and comorbidities
  • Integration of evidence-based nutrition protocols tailored to GLP-1 therapy

Program Methodology

A structured, three-step clinical pathway

1

Baseline Clinical Assessment

Detailed evaluation of:

  • Current dietary intake
  • Lifestyle factors (sleep, activity, stress)
  • Existing metabolic or chronic conditions
  • Identification of risk factors for GI intolerance and nutritional gaps
2

Personalized 10-Day Adaptation Protocol

Customized plan based on:

  • GLP-1 dosage and titration phase
  • Individual metabolic profile

Focus areas:

  • Portion recalibration
  • Meal timing and composition
  • Hydration and fiber optimization

Goal: Facilitate physiological adaptation and minimize adverse effects.

3

Continuous Monitoring & Follow-ups

Regular, structured follow-ups to:

  • Track GI symptoms and tolerance
  • Adjust dietary protocols dynamically
  • Reinforce adherence and patient education
Clinical tools, notebook and berries representing nutrition consultation
A balanced healthy meal bowl with salmon, greens and quinoa

Expected Outcomes

What patients and clinicians can expect

  • Reduction in early-stage GI side effects
  • Improved patient adherence to GLP-1 therapy
  • Better nutritional adequacy despite reduced appetite
  • Enhanced weight loss and metabolic outcomes
  • Increased patient confidence and satisfaction

A comprehensive care ecosystem around GLP-1 therapy

  • Supports holistic patient management alongside pharmacotherapy
  • Improves real-world treatment outcomes and persistence rates
  • Reduces drop-offs due to side effects
  • Positions therapy within a comprehensive care ecosystem

Bring structured nutritional care to your GLP-1 patients

Connect with our clinical team to learn how the program integrates with your treatment plan.

Book a Consultation